Comparative Pharmacology
Head-to-head clinical analysis: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE versus THIOTHIXENE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE versus THIOTHIXENE.
PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE vs THIOTHIXENE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Perphenazine is a phenothiazine antipsychotic that blocks postsynaptic dopamine D2 receptors in the mesolimbic system, with additional antagonism at serotonin 5-HT2, alpha-1 adrenergic, histamine H1, and muscarinic M1 receptors. Amitriptyline is a tricyclic antidepressant that inhibits serotonin and norepinephrine reuptake, also antagonizing histamine H1, alpha-1 adrenergic, and muscarinic M1 receptors.
Thiothixene is a typical antipsychotic that blocks postsynaptic dopamine D1 and D2 receptors in the brain. It also has alpha-adrenergic and histamine H1 blocking activity, with minimal anticholinergic effects.
Oral: Perphenazine 2-4 mg with amitriptyline 10-50 mg, administered 3-4 times daily. Maximum daily dose: perphenazine 24 mg, amitriptyline 150 mg.
Initial: 2 mg orally three times daily; maintenance: 5-30 mg/day orally in divided doses; maximum: 60 mg/day. IM: 4 mg 2-4 times daily; maximum 30 mg/day.
None Documented
None Documented
Clinical Note
moderateThiothixene + Deferasirox
"The serum concentration of Deferasirox can be increased when it is combined with Thiothixene."
Clinical Note
moderateThiothixene + Fluticasone propionate
"The risk or severity of adverse effects can be increased when Thiothixene is combined with Fluticasone propionate."
Clinical Note
moderateThiothixene + Tenofovir disoproxil
"The metabolism of Tenofovir disoproxil can be decreased when combined with Thiothixene."
Clinical Note
moderatePerphenazine: ~9-12 hours (range 8-20 h). Amitriptyline: ~15-24 hours (range 10-50 h). Clinical context: Steady-state reached in 3-10 days; amitriptyline's active metabolite nortriptyline has T½ ~18-35 h.
Terminal half-life: 10-20 hours (mean ~14 h). Clinical context: Steady-state achieved in ~2-3 days; allows once-daily dosing for maintenance.
Perphenazine: renal (0.5-2% unchanged), hepatic metabolism and biliary/fecal elimination (major). Amitriptyline: renal (<5% unchanged, 30-50% as metabolites), biliary/fecal (significant). Combined: ~70-80% renal (metabolites), ~20-30% fecal.
Primarily renal: 65-70% as metabolites, <1% unchanged. Fecal: 15-20% via biliary elimination.
Category A/B
Category C
Typical Antipsychotic
Typical Antipsychotic
Thiothixene + Methylphenidate
"The risk or severity of adverse effects can be increased when Thiothixene is combined with Methylphenidate."